General

Do CWA and web-based access also allow for individual saved searches?

Reaxys has this functionality. To allow the user to change the application settings, save queries and search history and set up alerts, s/he can set his/her own username/password by using REGISTER in Reaxys. After login queries can be loaded and saved locally on the workstation and results can be saved.

Is a username or password needed to access Reaxys?

We offer CWA-licenses (Corporate/Campus Wide Access) on a yearly subscription base including user authentication via IP-recognition - so no credentials needed here.

Can I evaluate Reaxys free of charge?

Yes - use CONTACT on www.info.reaxys.com to ask for a free trial.

How can I stay up to date regarding Reaxys?

Visit the Reaxys website www.info.reaxys.com regularly for updates. You will also find a contact form to sign up for the newsletter, background about the team behind Reaxys, information about forthcoming conferences and events where you can have a demo of Reaxys.

Who are the members of the Reaxys Advisory Board?

Members of the Reaxys Advisory Board include:

  • Dr. James E. Audia, Eli Lilly, Indianapolis, IN, USA
  • Prof. A.G.M. Barrett, Imperial College, London, UK
  • Prof. Dr. Erick M. Carreira, ETH Zürich, Switzerland
  • Prof. Robert H. Grubbs, California Institute of Technology, Pasadena, CA, USA
  • Dr. Torsten Hoffmann, F. Hoffmann-La Roche Ltd., Basel, Switzerland
  • Prof. Dr. Horst Kunz, University of Mainz, Germany
  • Dr. Ge Li, WuXi PharmaTech, Shanghai, China
  • Dr. Graeme Robertson, Siena Biotech, Siena, Italy
  • Dr. K.

What is the role of the Reaxys Advisory Board (RAB)?

The RAB provides us with strategic guidance for the development of  Reaxys and ensure that we can tap into the necessary chemistry expertise to guide the products. Their roles include advising us on content coverage and functionality and, in general, representing the needs and views of the chemistry community at large. We are delighted that the Board includes so many eminent chemists including Nobel Laureates Bob Grubbs and Barry Sharpless.

Who is participating in the Development Partner program?

Among the current development partners are:

  • Boehringer Ingelheim
  • Fujitsu
  • Informationszentrum Chemie Biologie Pharmazie ETH Zürich
  • Mercachem
  • Novasep
  • University of Bath
  • Vienna University of Technology
  •  Plus thirteen more partners

What is the role of the Development Partners?

Our Development Partners are a direct link to customers and end users in industry, academia and government institutions. They provide Reaxys with ideas and feedback on usability and functionality. The Development Partners contribute by thoroughly testing the interface for usability and product features, as well as providing ideas for future development.

Why do we work with Development Partners?

Elsevier is committed to serving the needs of customers. Therefore, the customer is at the heart of all that we do. As Reaxys evolves, we will work closely with customers to develop new content and functionalities that support the way that they work. We are keen to be a partner for our customers in the synthesis design planning process and help them achieve their scientific goals.

How does Reaxys deal with firewall security?

Security is one of our biggest concerns and therefore Reaxys is accessible using HTTPS protocol. This requires port 443 to be open in a company’s firewall. Since this is a standard setting, it should not be a problem, unless the company prohibits all internet access.


Terms & Conditions | Privacy Policy
Copyright © 2010 Elsevier Properties SA. All rights reserved.
Reaxys ® is a trademark owned and protected by Elsevier Properties SA and used under license. Syndicate content